ABSTRACT Introduction Multiple Sclerosis (MS), as an autoimmune disease, has
complicated immunopathology, which makes its management relevant to various factors …

Multiple sclerosis (MS) is an immune‐mediated demyelinating disease of the central
nervous system which leads to neurological dysfunctions and severe disabilities. MS …

Immune-based inflammatory diseases involve immune related dysregulation in different
sites of body, which includes rheumatoid arthritis, multiple sclerosis, inflammatory bowel …

Multiple sclerosis (MS) is an autoimmune disease of the Central Nervous System,
characterized by an inflammatory process leading to the destruction of myelin with neuronal …

Inflammatory diseases are considered to be highly dreadful ones responsible for higher
mortality in the developed countries. This includes cancer, psoriasis, rheumatoid arthritis …

Current available treatments of Multiple Sclerosis (MS) reduce neuroinflammation acting on
different targets on the immune system, but potentially lead to severe side effects and have a …

Liposomes can be seen as ideal carriers for anti-inflammatory drugs as their ability to
(passively) target sites of inflammation and release their content to inflammatory target cells …

This review focuses on the therapeutic utility of liposomes in the treatment of inflammatory
disorders, and aims to offer the reader an overview of the in vivo results obtained with …

Aim: Based on the ability of apoptosis to induce immunological tolerance, liposomes were
generated mimicking apoptotic cells, and they arrest autoimmunity in Type 1 diabetes. Our …

Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous
system, which is accompanying with demyelination, neurodegeneration and sensibility to …